Recall Weekly
Moderate riskFDA DrugClass II

Victory Medical Center tirzepatide vials recalled for processing gaps

Victory Medical Center Pharmacy in Austin, Texas, is recalling 104 vials of compounded tirzepatide/B6 (25mg/10mg per mL, 1 mL) from lot 2012330. The FDA classified the recall as Class II due to a lack of processing controls. No injuries have been reported.

From the FDA notice · Read the official notice ↗ · All Victory Medical Center Pharmacy recalls

What to do

  1. Check whether you have lot 2012330 with expiration date 10/24/2026.
  2. Stop using vials from this lot and do not share them.
  3. Contact Victory Medical Center Pharmacy or your prescriber about a replacement or disposal.
Official notice ↗

Is yours affected?

Compare your label or packaging with the recalled product.

Product
TIRZEPATIDE/B6 (MDV) 25MG/10MG/ML **1ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas
Sold in
CO, FL, TX

This recall covers 42 products — see all of them.

Details

Units affected
104 vials
Illnesses reported
None reported
Manufactured in
4303 Victory Dr, Austin, Texas, United States
Classification
Class II
Recall number
D-0147-2027

In the FDA's words

Description
TIRZEPATIDE/B6 (MDV) 25MG/10MG/ML **1ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas Lack of Processing Controls Lot, expiry: Lot 2012330 , exp 10/24/2026 Distribution: CO, FL, TX Affected quantity: 104 vials
Hazard
Lack of Processing Controls

42 products in this recall

Victory Medical Center injectables recalled for lack of processing controls

Victory Medical Center Pharmacy is recalling 42 injectable vial products because of a lack of processing controls. The products were distributed in Colorado, Florida, and Texas, and include alpha lipoic acid, ascorbic acid, B complex, BPC-157, CJC-1295, dexamethasone, methylcobalamin, and NAD+, among others. No injuries have been reported.

The agency lists each product separately. Check every one you might have.

More from Victory Medical Center Pharmacy

See all

Related topics

DrugsCOFLTXMore from FDA Drug